Activist Investor Demands Exelixis Cut R&D Spending And Learn From Peers
CEO Pushes Back On R&D Spending Cut Calls
The mid-sized company is under siege from hedge fund Farallon and faces a fight over its R&D strategy to follow aging blockbuster Cabometyx.